The efficacy and safety of dupilumab in Chinese patients with moderate-to-severe atopic dermatitis: a randomized, double-blind, placebo-controlled study.
Yan ZhaoL WuQ LuX GaoX ZhuXu YaoLin-Feng LiWei LiY DingZ SongL LiuN DangC ZhangX LiuJ GuJ WangSongmei GengQ LiuY GuoL DongH SuL BaiJ T O'MalleyJ LuoE LawsL MannentM RuddyN AminAshish BansalT OtaM WangJ ZhangPublished in: The British journal of dermatology (2021)
In adult Chinese patients, dupilumab was effective in improving the signs and symptoms of AD and demonstrated a favourable safety profile.